No Data
No Data
OraSure to Present at the J.P Morgan Healthcare Conference
Express News | OraSure Technologies Shares up 4% Premarket After Oraquick® Hiv Self-Test Approved for Use in Adolescents
OraQuick HIV Self-Test Gains Approval For Adolescents, Expanding Access To HIV Testing For Ages 14 And Up
Evercore Maintains OraSure Technologies(OSUR.US) With Hold Rating, Cuts Target Price to $4
OSUR Stock Rises Following the Acquisition of Sherlock Biosciences
Express News | OraSure Technologies Inc - Sherlock's Ct/Ng Self-Test Expected to Be Submitted to FDA by End of 2025